// App-Quantinova.ai

: Generating Plasma Protein Signatures for Murine Venous Thrombosis and Slc44a2 Deficiency Using a Multiplex Targeted Proteomics Approach

Researchers

Presenter

  • J. Tilburg

Principal Investigators

  • S.A. Michaud

  • C.X. Maracle

  • C.H. Borchers

  • H.H. Versteeg

  • B.J.M. van Vlijmen

  • Y. Mohammed

Medical Centers

  • Leiden University Medical Center, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden, the Netherlands

  • Univ of Victoria-Genome British Columbia Proteomics Ctr, Victoria, BC, Canada

  • McGill University, Molecular Pathology, Montreal, Canada

  • Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, the Netherlands

Locations

  • Netherlands

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Protein C

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved